Cargando…
Implications for Drug Characterization in Glucose Tolerance Tests Without Insulin: Simulation Study of Power and Predictions Using Model‐Based Analysis
In antihyperglycemic drug development, drug effects are usually characterized using glucose provocations. Analyzing provocation data using pharmacometrics has shown powerful, enabling small studies. In preclinical drug development, high power is attractive due to the experiment sizes; however, insul...
Autores principales: | Sheikh Ghadzi, SM, Karlsson, MO, Kjellsson, MC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658280/ https://www.ncbi.nlm.nih.gov/pubmed/28575547 http://dx.doi.org/10.1002/psp4.12214 |
Ejemplares similares
-
Study Design Selection in Early Clinical Anti‐Hyperglycemic Drug Development: A Simulation Study of Glucose Tolerance Tests
por: Ibrahim, Moustafa M. A., et al.
Publicado: (2018) -
Weight‐HbA1c‐insulin‐glucose model for describing disease progression of type 2 diabetes
por: Choy, S, et al.
Publicado: (2015) -
Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP‐1
por: Leohr, Jennifer, et al.
Publicado: (2023) -
Prediction of Glucose Tolerance without an Oral Glucose Tolerance Test
por: Babbar, Rohit, et al.
Publicado: (2018) -
Model‐Based Interspecies Scaling of Glucose Homeostasis
por: Alskär, Oskar, et al.
Publicado: (2017)